Supplementary digital material
Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders
Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression
Neuroprotection in Multiple Sclerosis: A Therapeutic Approach
Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach
Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients
Comment on: “Management of Alcohol Dependence in Patients With Liver Disease”
Authors' Reply to Rolland et al.: “Management of Alcohol Dependence in Patients with Liver Disease”